• N. Engl. J. Med. · Jan 2023

    Comment Letter

    Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply.

    • David Rosmarin, Deanna Kornacki, and Khaled Ezzedine.
    • Tufts Medical Center, Boston, MA drosmarin@tuftsmedicalcenter.org.
    • N. Engl. J. Med. 2023 Jan 19; 388 (3): 284284.

    no abstract available

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.